Clinical Trials Logo

Pilonidal Sinus clinical trials

View clinical trials related to Pilonidal Sinus.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06406621 Not yet recruiting - Pilonidal Sinus Clinical Trials

Laser Hair Depilation Darker Skin Pilonidal Disease

Start date: March 2025
Phase: N/A
Study type: Interventional

Pilot randomized trial assessing the effectiveness of laser hair depilation on pilonidal disease recurrence in patients with darker skin color

NCT ID: NCT06378918 Not yet recruiting - Pilonidal Cyst Clinical Trials

Comparison of the Effectiveness of the Simple Puncture Compared to the Incision of an Abscess on the piLOnidal Sinus

PILO
Start date: June 15, 2024
Phase: N/A
Study type: Interventional

Pilonidal disease is a common disease characterized by the presence of abscess in the intergluteal groove. During periods of abscess, current recommendations are to make a simple incision with daily wicking of the abscess. Direct excision at this time is not recommended because there is a risk of incomplete excision. The principle of directed healing after incision of the abscess results in an average dressing period of 21 days. A definitive resection is recommended after 4 to 6 weeks, when healing has been achieved, in order to limit the risk of infectious recurrence. An alternative has recently been proposed, consisting of a puncture of the abscess, aimed at emptying it under antibiotic coverage. The major advantage of this treatment is that patients no longer need general anesthesia to flatten the abscess. Although this technique is promising, it is currently not the subject of any published or ongoing randomized controlled study registered on Clinicaltrials.gov. The research hypothesis is that the two techniques have the same results in terms of recurrence before definitive surgical treatment but that drainage puncture would imply a faster healing time, a lower cost of treatment, a quality of superior support, reduced support time and reduced work stoppage.

NCT ID: NCT06286397 Not yet recruiting - Pilonidal Sinus Clinical Trials

Topical Anti-Androgens in Pilonidal Sinus Disease

Start date: May 1, 2024
Phase: Phase 2
Study type: Interventional

The goal of this randomized clinical trial is to test the topical drug clascoterone in patients with pilonidal disease, which is a common, benign skin condition of the gluteal cleft. The main questions it aims to answer are: - Does clascoterone improve the severity of pilonidal disease as scored by a physician? - Does clascoterone improve patient symptoms due to pilonidal disease? - Does clascoterone improve the inflammation seen under the microscope in pilonidal disease removed at surgery Participants will apply clascoterone or a placebo cream to the diseased area for 3 months. They will be assessed every 4 weeks for disease severity assessed by a physician viewing patient photos and a symptom-based survey. Researchers will compare participants who received clascoterone treatment to those who received placebo.

NCT ID: NCT06152952 Not yet recruiting - Clinical trials for Pilonidal Sinus Infected

Rhomboid Flap vs. Deep Suturing in Recurrent Pilonidal Sinus

Start date: December 2023
Phase:
Study type: Observational [Patient Registry]

This prospective clinical trial aims to compare the perioperative outcomes of rhomboid flap versus deep suturing in the management of recurrent sacrococcygeal pilonidal disease.

NCT ID: NCT06140199 Not yet recruiting - Pilonidal Sinus Clinical Trials

Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)

LA POPA
Start date: May 2024
Phase: N/A
Study type: Interventional

The goal of this randomized clinical trial is to establish the efficacy of 'pit picking with laser therapy' versus 'pit picking alone' on both short and long-term outcomes in patients of 12 years and older with primary pilonidal sinus disease. The main questions it aims to answer are: - The overall success rate of treatment which is defined as: closure of all pits at 12 months of follow-up. - Secondary endpoints: succes rat eof treatment during long-term follow-up, wound closure time, pain scores, complication rate, work rehabilitation, time to return to daily activities, quality of life, persisting complaints, patient satisfaction, costs and the need for secondary or revision surgery. Participants will allocated to pit picking alone or combined with lasertherapy. The extra burden for participating patients is expected to be minimal to moderate. Participants will have two extra hospital visits in casethey are enrolled in our study: 6 and 12 months after enrolment. Postoperatively the normal scheme of follow up appointments wil be used: 2 and 6 weeks after treatment at the outpatient clinic of the treating surgeon. A telephone appointment with the researcher will be scheduled 4 weeks after treatment. Patients are asked to complete questionnaires at various time points, which will be sentto them by email and will take approximately 5-10 minutes each time. The content includes general and disease specific Quality of Life (QoL) questionnaires. The investigators do not expect any extra adverse reactions or events in respect to participation in the study because both procedures are considered standard of care in the participating clinics. However, because both interventions are surgical procedures a small percentage of adverse events or postoperative complications can be expected.

NCT ID: NCT06021392 Not yet recruiting - Pilonidal Sinus Clinical Trials

Comparative Study Between Wide Local Excision and Minimal Excision of Pilonidal Sinus

Start date: December 1, 2023
Phase:
Study type: Observational

Comparative study between wide local excision and minimal excision of pilonidal sinus

NCT ID: NCT04273997 Not yet recruiting - Pilonidal Sinus Clinical Trials

Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds

Start date: October 1, 2021
Phase: Phase 2
Study type: Interventional

Title of Study: Randomised, double-blind, placebo-controlled trial evaluating the effects of metronidazole ointment in facilitating resolution on non-healing pilonidal sinus wounds Medical Condition Under Investigation Non-healing pilonidal sinus wounds Study centres: 2 Centres in Turkey Clinical Phase: Phase 2 Protocol Number: MET-PS-02 Study Design: Randomised, double-blind, placebo-controlled, parallel group study to determine the safety and efficacy of metronidazole ointment applied to the wound, following debridement in non-healing pilonidal sinus wounds. Planned Sample Size: 80 subjects

NCT ID: NCT03415347 Not yet recruiting - Pilonidal Disease Clinical Trials

De-roofing and Curettage vs WLE for Pilonidal Abscess

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Pilonidal disease refers to a common disease affecting mostly young males. It may present as asymptomatic pits, acute and painful abscess formation, or chronic discharging sinuses. There are many treatment options for the latter two manifestations but broadly speaking the surgical treatment of acute pilonidal abscess can fall into three categories: (1) incision and drainage, (2) de-roofing and curettage and (3) wide local excision. The evidence available for the surgical management of acute pilonidal abscess is limited. Previous studies have consistently demonstrated that incision and drainage results in high recurrence rates and should not be considered as the first-line treatment option for the management of acute pilonidal abscess. However, it is not clear whether abscess de-roofing with curettage or wide local excision should be considered as the surgical procedure of choice in acute pilonidal abscess. There has not been a prospective randomised study comparing abscess de-roofing with curettage and wide local excision for acute pilonidal abscess. The ideal surgical procedure would be one that results in the lowest rate of abscess recurrence, treats the underlying pilonidal sinus thereby reducing the need for re-operation but has acceptable post-operative pain, complications and time to complete wound healing.